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Genetic interaction between PTCH1 and DLL3 SNPs and summary of subject statistics
PTCH1 (Chr9q22.32) 	 DLL3 (Chr19q13.2) Case/control frequency (%) OR (95% CI)
rs357552 (A/G) rs10512248 (A/C) rs2354225 (A/G)  
AG or AA AA GG 24.85/15.40 2.78 (1.717–4.514)
AG or AA AC + CC GA + AA 24.28/15.60 2.64 (1.627–4.281)
GG AA GA + AA 9.25/6.19 2.53 (1.277–5.021)
AG or AA AA GA + AA 9.82/9.17 1.82 (0.958–3.440)
MDR identified that 2 SNPs in PTCH1, rs357552 and rs10512248, and 1 SNP in DLL3, rs2354225, were the most relevant on driving the correlation of 
Hh and Notch pathways. Shown are specific genotype constellations of PTCH1 and DLL3 SNPs, with risk alleles (for rs357552, A; for rs10512248, C; 
for rs2354225, A) denoted underlined. Case/control frequencies and corresponding risks for HSCR are also shown; genotype constellations are listed in 
descending order according to risk. Other low-risk genotypes returned a case/control frequency of 31.80/53.90.
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Shh upregulates Dll1 expression to mediate proliferation of ENCCs. (A) BrdU proliferation assay showed that Shh (3 days) significantly 
(P < 0.001) increases the proliferation of ENCC progenitors (BrdU+/Ret+). This effect could be counteracted by treatments with DAPT (10 mM). 
Scale bar: 100 μm. Ctrl, control. (B) Proliferating Ret-expressing cells that incorporated with BrdU (for 16 hours) were counted. The values 
reported in bar charts represent the mean ± SEM, and 3 independent experiments were performed. Data were analyzed by 1-way ANOVA, 
followed by the Tukey post-hoc test. P values of less than 0.05 are statistically different from those of the control. (C) Semiquantitative RT-PCR 
for the Notch pathway genes after treatment with Shh in presence or absence of the Notch inhibitor DAPT (10 mM) (3 days). (D and E) Quan-
titative RT-PCR (qRT-PCR) for the expression of Dll1 and Hes1 in ENCCs treated with Shh, Shh plus DAPT, and Hh agonist, purmorphamine 
(Pur, 1 mM) (3 days). (F) Knockdown of Dll1 significantly abrogated the Shh-mediated proliferation (3 days). Quantitative RT-PCR for the 
expression of Dll1 shows that siRNA can significantly downregulate Dll1 expression (3 days). Nonsilencing RNA (NS) was used as a negative 
control. Bars represent the mean ± SEM, and 3 independent experiments were performed, each in triplicate. P values of less than 0.05 were 
considered to be statistically significant.
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Deletion of Ptch1 promotes the proliferation and gliogenesis but inhibits neurogenesis of ENCCs. (A) ENCCs were isolated from the Ptch1f/f 
mice, which have loxP recombinase recognition sites flanking exon 3 of the Ptch1 gene. The Ptch1f/f ENCCs were then infected with Ad-GFP-
Cre. 86.0% ± 1.3% of ENCCs expressed GFP 72 hours after the infection with the control virus (Ad-GFP) and Ad-GFP-Cre. Primers were 
designed to generate a PCR product that spanned exon 2 to 6 (ex 2-6) of Ptch1 to distinguish full-length and exon 3–deleted Ptch1 transcripts. 
Another pair of primers was designed at exon 20 and 22 for the comparison of Ptch1 expression. Exons are represented by rectangles, and 
loxP sites are represented by triangles. Scale bar: 100 μm. (B) The expression of the mutant Ptch1 and other Hh target genes was analyzed by 
RT-PCR in presence or absence of Shh (transduction for 4 days followed by Shh treatment for 3 days). (C) BrdU proliferation assay. Relative 
proliferation rates were measured by counting BrdU+/Ret+ and total Ret+ cells. (D and E) Immunocytochemistry. Neuronal and glial differentia-
tion was monitored based on the expression of TH and S100β, respectively (GDNF treatment for 10 days). Percentages of (D) neuronal and (E) 
glial precursors were measured over the total number of ENCCs (DAPI). (F) Quantitative RT-PCR showed that deletion of Ptch1 (Ad-GFP-Cre) 
induces GFAP expression. The values reported in bar charts represent the mean ± SEM, and 3 independent assays were performed. Data 
were analyzed by 1-way ANOVA, followed by the Tukey post-hoc test. P values of less than 0.05 were considered to be statistically significant.
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Deletion of Ptch1 in ENCCs robustly activates the Notch pathway. (A) Quantitative RT-PCR showed that Cre adenovirus–mediated deletion 
of Ptch1 in ENCCs (Ad-GFP-Cre) resulted in elevated expression of Dll1 and Hes1 compared with that of the cells infected with control virus 
(Ad-GFP) (4 days). (B) Western blot analysis showed that deletion of Ptch1 induces a robust expression of NICD. (C) BrdU proliferation 
assay indicated that deletion of Ptch1 (Ad-GFP-Cre) promotes the proliferation of ENCCs, while knockdown of Dll1 using siRNA (3 days) 
significantly reduces the proliferation of Ptch1–/– ENCCs. Nonsilencing RNA was used as a negative control. Error bars indicated mean 
± SEM, and 3 independent experiments were performed. (D) Immunocytochemistry showed that Shh or Dll1 alone is sufficient to induce 
the gliogenesis of ENCCs. ENCCs were treated with Shh (2 μg/ml), Dll1 (1 μg/ml), or a combination for 8 days, and cells were fixed and 
subjected to immunostaining with anti-GFAP antibody. GFAP+ (red) cells are glia. Scale bar: 100 μm. (E) Immunocytochemistry analyses 
indicated that addition of DAPT significantly abolishes Hh-mediated glial differentiation. ENCCs were treated with Shh (2 μg/ml), DAPT 
(10 mM), or a combination for 8 days, and cells were fixed and subjected to immunostaining with anti-GFAP antibody. Quantitative data 
are shown in bar chart. Error bars indicated mean ± SEM, and 3 independent experiments were performed. Data were analyzed by 1-way 
ANOVA followed by the Tukey post-hoc test. P values of less than 0.05 were considered to be statistically significant.
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Aberrant Hh signaling reduces enteric progenitors and induces prema-

















































Sustaining Hh signaling reduces proliferative ENCCs in mice. (A) Proliferation of ENS progenitors in E11.5 control (Ptch1f/f) and conditional 
Ptch1 knockout (Ptch1f/f/Wnt1-Cre) guts was analyzed by immunofluorescence for Ki67 (green) and p75NTR (red). Proliferating ENCCs 
(p75NTR+, Ki67+; arrowheads) and nonproliferating ENCCs (p75NTR+, Ki67–; arrows) were identified and counted in control and mutant guts. 
Boxed regions are shown at higher magnification in insets. st, stomach; mg, midgut. (B) The percentages of proliferative ENCCs in control 
and mutant guts were calculated and are shown in the bar chart. Error bars indicated ± SEM across 10 control (Ptch1f/f) and 7 mutant 
(Ptch1f/f/Wnt1-Cre) mice. Scale bar: 50 μm.
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Deletion of Ptch1 in ENCCs upregulates the expression of Hes1 and Dll1. (A) Immunohistochemical analyzes were performed on E11.5 
control (Ptch1f/f) and conditional Ptch1 mutant (Ptch1f/f/Wnt1-Cre) guts with anti-Hes1 and Tuj1 antibodies (Tuj1+, Hes1+; arrowheads). 
Boxed regions are shown at higher magnification in insets. Scale bar: 50 μm. (B) The percentages of Hes1+ cells in controls and mutants 
were measured over the total number of Tuj1+ cells and are shown in the bar chart. Error bars indicated ± SEM across 3 controls (Ptch1f/f) 
and mutants (Ptch1f/f/Wnt1-Cre). (C and D) Quantitative RT-PCR for the expression of (C) Hes1 and (D) Dll1 in ENCCs isolated from E11.5 
control (Ptch1f/f) and mutants (Ptch1f/f/Wnt1-Cre). Error bars indicated ± SEM across 4 controls (Ptch1f/f) and 4 mutants (Ptch1f/f/Wnt1-Cre).
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Ptch1 mutant exhibits premature gliogenesis. (A) In situ hybridization was used to examine the expression of glial marker (Fabp7) on E12.5 
control (Ptch1f/f) and Ptch1 mutant (Ptch1f/f/b3-IIIa-Cre) guts. Boxed regions are shown at higher magnification to the right. Scale bar: 50 μm. (B) 
Quantitative RT-PCR data on the expression of Fabp7 in E12.5 control (Ptch1f/f) and mutant (Ptch1f/f/Wnt1-Cre) guts is shown in the bar chart. 
Error bars indicated ± SEM across 5 control (Ptch1f/f) and 5 mutants (Ptch1f/f/Wnt1-Cre). Data was analyzed by Student’s t test. P values of less 
than 0.05 were considered to be statistically significant.
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Hh induces gliogenesis of SKPs. (A) SKPs isolated from human 
foreskin could give rise to cells expressing neuronal and glial 
markers. SKP spheres were obtained 2 to 3 weeks after culture. 
Immunocytochemistry showed that SKPs express precursor marker 
(vimentin, green). Two weeks after culturing in the differentiation medi-
um, cells expressing neuronal (neurofilament [NFM+], red) and glial 
(GFAP, red) markers were observed. Cells were counterstained with 
DAPI (blue). Scale bar: 50 μm. (B) The percentages of glial (GFAP+) 
cells in untreated control and Shh-treated culture were counted over 
total number of cells (DAPI). Error bars indicated ± SEM of triplicates. 
Data was analyzed by t test. P values of less than 0.05 were consid-
ered to be statistically significant.
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